Should the scientists at University College in London sell the drug that they made called CPHPC?
Scientists plan trials for Alzheimer’s drug by JAMES CHAPMAN, Daily Mail * Comments (0) * Add to My Stories British scientists have developed a drug that could stop the progress of Alzheimer’s disease. Research at University College London found that the drug is able to halt the advance of a related disease, known as amyloidosis. They now plan to launch a trial on patients with Alzheimer’s to see whether it will prevent the build up of protein in the brain. There is currently no cure for the disease, which causes dementia in the elderly. Its victims include novelist Iris Murdoch and former U.S. president Ronald Reagan. Experts know that Alzheimer’s sufferers express an abnormal amount of a protein called betaamyloid, which collects in the brain and forms waxy plaques. A sufferer’s ability to learn and remember declines as these plaques grow. Patients with amyloidosis also accumulate fibrous material, but in their tissues and organs. University College London scientists have now develop
Scientists plan trials for Alzheimer’s drug by JAMES CHAPMAN, Daily Mail * Comments (0) * Add to My Stories British scientists have developed a drug that could stop the progress of Alzheimer’s disease. Research at University College London found that the drug is able to halt the advance of a related disease, known as amyloidosis. They now plan to launch a trial on patients with Alzheimer’s to see whether it will prevent the build up of protein in the brain. There is currently no cure for the disease, which causes dementia in the elderly. Its victims include novelist Iris Murdoch and former U.S. president Ronald Reagan. Experts know that Alzheimer’s sufferers express an abnormal amount of a protein called betaamyloid, which collects in the brain and forms waxy plaques. A sufferer’s ability to learn and remember declines as these plaques grow. Patients with amyloidosis also accumulate fibrous material, but in their tissues and organs. University College London scientists have now develop
http://psychcentral.com/news/2009/04/14/new-approach-for-alzheimers/5319.html New Approach for Alzheimer’s By Rick Nauert, Ph.D. Tuesday, Apr 14 (Psych Central) — Alzheimer’s is a progressive and fatal brain disease that affects as many as 5.3 million Americans. As America ages, the incidence of the disorder will rise. Consequently, a new therapeutic approach that targets a protein known as serum amyloid P component (SAP) holds promise. Professor Mark Pepys studied the protein for over 20 years and has now collaborated with drug manufacturer Roche Pharmaceuticals to develop a new small molecule drug, CPHPC, which specifically targets SAP and removes it from the blood. In the new work reported in the journal PNAS, the Pepys team together with Professor Martin Rossor and colleagues from the Dementia Research Centre of University College London’s Institute of Neurology, have shown t
